Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by LordoftheMarketon Jan 28, 2018 11:30pm
179 Views
Post# 27452062

2018 is going to be ISOL's Year

2018 is going to be ISOL's Year
One thing investors need to put into consideration is ISOL's Market Cap compared to its market peers in the sector. I call them market peers because one of these companies I will list below is Canopy Growth Ticker Symbol-WEED who are already doing business with Isodiol so I don't consider them competition for ISOL but business partners. 

1)Canopy Growth-Market Cap-$6.08 Billion 

2) Aurora-Market Cap- $
5,935,330,980 Billion

3) Aphiria-Market Cap-$3.06 Billion 

4) MedReleaf-Market Cap-$2.27 Billion Dollars

5) Canntrust-Market Cap-$1.04 Billion 

6) Isodiol-Market Cap-$299 Million 

Currently ISOL only has a $299 Million dollar Market Cap with compariable revenues to all these companies above which have Market Caps in the Billions.




 
 
Bullboard Posts